Moulin David, Salone Véronique, Koufany Meriem, Clément Thomas, Behm-Ansmant Isabelle, Branlant Christiane, Charpentier Bruno, Jouzeau Jean-Yves
Laboratoire d'Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), UMR 7365 CNRS-Université de Lorraine, Biopôle de l'Université de Lorraine, Campus Biologie-Santé, 9 avenue de la Forêt Haye, BP 20199, 54505 Vandœuvre-lès-Nancy Cedex, France.
Département de Pharmacologie Clinique et Toxicologie, Centre Hospitalier Universitaire, Hôpital Central, 29 avenue du Maréchal de Lattre-de-Tassigny, 54035 Nancy Cedex, France.
Biomed Res Int. 2017;2017:9792512. doi: 10.1155/2017/9792512. Epub 2017 May 22.
Decreased expression of collagen type II in favour of collagen type I or X is one hallmark of chondrocyte phenotype changes in osteoarthritic (OA) cartilage. MicroRNA- (miR-) 29b was previously shown to target collagens in several tissues. We studied whether it could contribute to collagen imbalance in chondrocytes with an impaired phenotype.
After preliminary microarrays screening, miR-29b levels were measured by RT- quantitative PCR in models of chondrocyte phenotype changes (IL-1 challenge or serial subculturing) and in chondrocytes from OA and non-OA patients. Potential miR-29b targets identified in 3'-UTRs of collagens mRNAs were tested with luciferase reporter assays. The impact of premiR-29b overexpression in ATDC5 cells was studied on collagen mRNA levels and synthesis (Sirius red staining) during chondrogenesis.
MiR-29b level increased significantly in IL-1-stimulated and weakly in subcultured chondrocytes. A 5.8-fold increase was observed in chondrocytes from OA versus non-OA patients. Reporter assays showed that miR-29b targeted COL2A1 and COL1A2 3'-UTRs although with a variable recovery upon mutation. In ATDC5 cells overexpressing premiR-29b, collagen production was reduced while mRNA levels increased.
By acting probably as a posttranscriptional regulator with a different efficacy on COL2A1 and COL1A2 expression, miR-29b can contribute to the collagens imbalance associated with an abnormal chondrocyte phenotype.
II型胶原蛋白表达减少而有利于I型或X型胶原蛋白表达,是骨关节炎(OA)软骨中软骨细胞表型改变的一个标志。此前研究表明,微小RNA(miR)-29b在多个组织中靶向胶原蛋白。我们研究了它是否会导致表型受损的软骨细胞中胶原蛋白失衡。
经过初步的微阵列筛选后,通过逆转录定量PCR检测软骨细胞表型改变模型(白细胞介素-1刺激或连续传代培养)以及OA和非OA患者软骨细胞中的miR-29b水平。对在胶原蛋白mRNA的3'-非翻译区中鉴定出的潜在miR-29b靶标进行荧光素酶报告基因检测。研究了在软骨形成过程中,pre-miR-29b过表达对ATDC5细胞中胶原蛋白mRNA水平和合成(天狼星红染色)的影响。
在白细胞介素-1刺激的软骨细胞中,miR-29b水平显著升高,在传代培养的软骨细胞中略有升高。与非OA患者相比,OA患者软骨细胞中的miR-29b水平升高了5.8倍。报告基因检测表明,miR-29b靶向COL2A1和COL1A2的3'-非翻译区,尽管突变后的恢复情况有所不同。在过表达pre-miR-29b的ATDC5细胞中,胶原蛋白产量降低,而mRNA水平升高。
miR-29b可能作为一种对COL2A1和COL1A2表达具有不同作用效果的转录后调节因子,导致与软骨细胞异常表型相关的胶原蛋白失衡。